Perfusion MR Imaging: Clinical Utility for the Differential Diagnosis of Various Brain Tumors

Korean Journal of Radiology

Volumn 3, Issue 3, 2002, Pages 171-179

  Cho, Sung Ki ^a   Na, Dong Gyu ^a   Ryoo, Jae Wook ^a   Roh, Hong Gee ^a   Moon, Chan Hong ^a   Byun, Hong Sik ^a   Kim, Jong Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Brain neoplasms, diagnosis; Brain neoplasms, MR; Brain, perfusion; Magnetic resonance (MR), perfusion study

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD VOLUME; BRAIN; BRAIN TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD VOLUME; BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0036654704     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2002.3.3.171     Document Type: Article

References (27)

1. Brunetti A, Alfano B, Soricelli A, et al. Functional characterization of brain tumors: an overview of the potential clinical value. Nucl Med Biol 1996;23:699-715
2. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174
3. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
4. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility - contrast NMR. Magn Reson Med 1990;14:538-546
5. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211:791-798
6. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
7. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995;36:520-528
8. Maeda M, Itoh S, Kimura H, et al. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR 1994;163:181-186
9. Bagley LJ, Grossman RI, Judy KD, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 1997;202:511-516
10. Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow-up of brain tumors. J Neurosurg 1997;86:22-27
11. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR 2000;174:1147-1157
12. Lee SJ, Kim JH, Kim YM, et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol 2001-2:1-7
13. Russell D, Rubinstein L. Tumours of central neuroepithelial origin. In: Rubinstein LJ, ed. Pathology of tumours of the nervous system. Baltimore: Williams & Wilkins, 1989:83-350
14. Glantz MJ, Burger PC, Herndon JE II, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-1744
15. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265
16. Weisskoff R, Belliveau J, Kwong K, Rosen B. Functional MR imaging of capillary hemodynamics. In: Potchen E, ed. Magnetic resonance angiography: concepts and applications. St Louis: Mosby, 1993:473-484
17. Berchtenbreiter C, Bruening R, Wu RH, et al. Comparison of the diagnostic information in relative cerebral blood volume, maximum concentration, and subtraction signal intensity maps based on magnetic resonance imaging of gliomas. Invest Radiol 1999;34:75-81
18. Bitzer M, Klose U, Nagele T, et al. Echo-planar perfusion imaging with high spatial and temporal resolution: methodology and clinical aspects. Eur Radiol 1999;9:221-229
19. Di Chiro G, Brooks R, Bairamian D, et al. Diagnostic and prognostic value of positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. In: Reivich M, Alavi A, eds. Positron emission tomography. New York: Liss, 1985:291-309
20. Brasch RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR 1984;142:625-630
21. Grossman I, Wolf G, Biery D, et al. Gadolinium-enhanced nuclear magnetic resonance images of experimental brain abscess. J Comput Assist Tomogr 1984;8:204-207
22. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR 1998;171:1479-1486
23. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin North Am 1999;9:309-331
24. Sugahara T, Korogi Y, Shigematsu Y, et al. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999;23:232-237
25. Lee SR, Sanches J, Mark AS, Dillon WP, Norman D, Newton TH. Posterior fossa hemangioblastomas: MR imaging. Radiology 1989;171:463-468
26. Ho VB, Smirniotopoulos JG, Murphy FM, Rushing EJ. Radiologic-pathologic correlation: hemangioblastoma. AJNR 1992;13:1343-1352
27. Martel AL, Allder SJ, Delay GS, Morgan PS, Moody AA. Perfusion MRI of infarcted and noninfarcted brain tissue in stroke: a comparison of conventional hemodynamic imaging and factor analysis of dynamic studies. Invest Radiol 2001; 36:378-385